Meixia Zhang
- Molecular Biology top 10%
- Immunology top 10%
- Ophthalmology top 2%
- Health, Toxicology and Mutagenesis top 5%
- Pharmacology top 2%
- Topics
- Retinal Diseases and Treatments (41 papers)Retinal Imaging and Analysis (23 papers)Retinal and Optic Conditions (21 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Meixia Zhang
138 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Molecular Biology 783
- Immunology 336
- Ophthalmology 315
- Health, Toxicology and Mutagenesis 265
- Pharmacology 236
Countries citing papers authored by Meixia Zhang
This map shows the geographic impact of Meixia Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meixia Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meixia Zhang more than expected).
Fields of papers citing papers by Meixia Zhang
This network shows the impact of papers produced by Meixia Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meixia Zhang. The network helps show where Meixia Zhang may publish in the future.
Co-authorship network of co-authors of Meixia Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Meixia Zhang. A scholar is included among the top collaborators of Meixia Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meixia Zhang. Meixia Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 4 | |
| 7 | 5 | |
| 8 | 7 | |
| 9 | 21 | |
| 10 | 3 | |
| 11 | 0 | |
| 12 | 1 | |
| 13 | 7 | |
| 14 | 7 | |
| 15 | Combined antitumor activity of cucurbitacin B and doxorubicin on hepatocellular carcinoma | 1 |
| 16 | Effect of cucurbitacin B on concentration of doxorubicin in hepatocellular carcinoma cells | 1 |
| 17 | Cultivation Situation and Prospect of Yacon Industry in China | 1 |
| 18 | [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients]. | 1 |
| 19 | The practice of performing examination feedback to improve the quality of teaching | 0 |
| 20 | 30 |
About Meixia Zhang
Meixia Zhang is a scholar working on Ophthalmology, Process Chemistry and Technology and Radiology, Nuclear Medicine and Imaging, having authored 151 papers that have together received 2.6k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (41 papers), Retinal Imaging and Analysis (23 papers) and Retinal and Optic Conditions (21 papers). The work is most often cited by research in Transplantation (205 citations), Ophthalmology (315 citations) and Pharmacology (236 citations). Meixia Zhang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Tieliu Shi, Zhenghui Yi, Chengping Wen, Rui Xue, Fang Zhao, Jianan Duan, Chunyan Lei, Jianyin Xiong, Fei Chen and Zhiwei Fan. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.